BreatheSuite
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | - | ||
$550k | Seed | ||
N/A | N/A | Early VC | |
* | CAD1.2m | Seed | |
* | N/A | Grant | |
Total Funding | CAD2.0m |
Related Content
Recent News about BreatheSuite
EditBreatheSuite is a healthcare technology company focused on improving the lives of individuals with chronic lung diseases such as COPD, asthma, interstitial lung disease, pulmonary fibrosis, bronchiectasis, and post-COVID lung disease. Operating primarily in the United States, BreatheSuite offers a virtual pulmonary rehabilitation (vPR) program that provides patients with the education and support they need to enhance their physical abilities and overall quality of life. The company serves Medicare patients, many of whom can access the program at no cost. BreatheSuite's business model revolves around partnering with healthcare providers and health plans to deliver its services. Revenue is generated through these partnerships and reimbursements from Medicare and other insurance providers. The company leverages technology to create a strong human connection, ensuring that patients receive personalized care and support. BreatheSuite's mission is to make breathing easier and improve the health outcomes of those suffering from respiratory diseases.
Keywords: virtual pulmonary rehab, chronic lung diseases, COPD, asthma, Medicare, healthcare technology, patient education, respiratory support, health plans, personalized care, improved quality of life.